As a result, these findings collectively elucidated the different functions SLC35A2 in oncogenesis and tumor progression in various cancers, with the potential to serve as a predictive biomarker for prognosis of STAD, which deserves further investigation. The gene discussed is SLC35A2; the disease is gastric adenocarcinoma.